Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 7/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | INPP5D | Q92835 | 2/20 | 0.47 |
| ▸ | NPC1L1 | Q9UHC9 | 4/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | CDC25A | P30304 | 3/20 | 0.39 |
| ▸ | POLA1 | P09884 | 1/20 | 0.38 |
| ▸ | CDC25B | P30305 | 1/20 | 0.37 |
| ▸ | HMGCR | P04035 | 1/20 | 0.36 |
| ▸ | FNTA | P49354 | 1/20 | 0.35 |
| ▸ | FNTB | P49356 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29367210 | 0.69 | ATP1A1 (0.55) | EBPCYP2D6CYP2C19INPP5DNPC1L1 | |
| SCHEMBL14886861 | 0.69 | CYP2D6 (0.67) | EBPCYP2D6CYP2C19INPP5DNPC1L1 | |
| SCHEMBL13185816 | 0.67 | EBP (0.55) | EBPNPC1L1MEN1USP2LMNA | |
| SCHEMBL18714859 | 0.67 | EBP (0.55) | EBPINPP5DNPC1L1MEN1USP2 | |
| SCHEMBL17487215 | 0.67 | EBP (0.55) | EBPINPP5DNPC1L1MEN1USP2 | |
| SCHEMBL18714858 | 0.67 | EBP (0.55) | EBPINPP5DNPC1L1MEN1USP2 | |
| SCHEMBL17487216 | 0.67 | EBP (0.55) | EBPINPP5DNPC1L1MEN1USP2 | |
| SCHEMBL1937432 | 0.66 | CYP2D6 (0.60) | CYP2D6CYP2C19INPP5DNPC1L1MEN1 | |
| SCHEMBL19957934 | 0.65 | CYP2D6 (0.65) | CYP2D6CYP2C19INPP5DNPC1L1MEN1 | |
| SCHEMBL23645781 | 0.65 | CYP2D6 (1.00) | CYP2D6CYP2C19INPP5DNPC1L1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8790664-B2 | Multimodular assembly useful for intracellular delivery | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2014-07-29 | — | — | US | disclosed |
| US-20120058139-A1 | NOVEL MULTIMODULAR ASSEMBLY USEFUL FOR INTRACELLULAR DELIVERY | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2012-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120058139-A1 | NOVEL MULTIMODULAR ASSEMBLY USEFUL FOR INTRACELLULAR DELIVERY | PICALM, CHMP4B, CLTB | EBP 4043/4885CYP2D6 4875/4885CYP2C19 4878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.